Prosecution Insights
Last updated: November 18, 2026

Phamri Norden AB

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Phamri Norden AB currently has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This matter is assigned to 1 distinct examiner, BARSKY, JARED, who is also the busiest examiner for the company. The presence of a single pending office action indicates a focused prosecution stage. Since the portfolio is currently managed by 1 distinct examiner, the company's success in this technology area depends on addressing the specific concerns of this individual.

The portfolio is concentrated in 1 distinct art unit, which aligns with the single pending office action in Biotechnology & Pharmaceuticals. With BARSKY, JARED handling the 1 pending office action, there is no diversification across different art units or examiners at this time. The alignment of the pending workload with 1 distinct examiner and 1 distinct art unit suggests a very specific technical and procedural path for the company's current intellectual property. Practitioners should tailor their approach to the specific requirements of the assigned examiner.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BARSKY, JARED 1 50.2% +22.9%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18274078 METHOD OF TREATING A SKIN DISORDER BARSKY, JARED —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18274078 METHOD OF TREATING A SKIN DISORDER BARSKY, JARED —

Top Art Units

Art UnitApps
1628 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18274078 METHOD OF TREATING A SKIN DISORDER BARSKY, JARED 1628 §102§103 Non-Final OA — Pending Jul 25, 2023

Managing Phamri Norden AB's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Phamri Norden AB have?

Phamri Norden AB has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Phamri Norden AB applications?

Jared Barsky has the most, with 1 of Phamri Norden AB's pending office actions.

What technology area are Phamri Norden AB's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month